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Abstract 
Few population-based studies have addressed the role that family history of colorectal cancer (CRC) plays in clinician 
decision making or patient health choices. The objective of this study was to evaluate the effect of family history of CRC on 
clinician practice, patient CRC screening, and patient preventive behavior. We analyzed 2008 Oregon Behavioral Risk 
Factor Surveillance System data to examine associations between family history of CRC and 1) patient-reported clinician 
recommendations, 2) perceived risk of developing CRC, 3) adoption of preventive and screening behaviors, and 4) CRC risk 
factors among 1,795 respondents without CRC. A family history of CRC was positively associated with a higher likelihood of 
respondents reporting that their clinicians discussed colorectal cancer screening (OR, 4.2; 95% CI, 2.4-7.4) and of 
respondents having colorectal screening within the recommended time period (OR, 2.2; 95% CI, 1.3-3.9). A family history of 
CRC was also associated with respondents reporting lifestyle changes to prevent CRC (OR, 2.6; 95% CI, 1.7-4.0). A family 
history of CRC may prompt clinicians to recommend screening and preventive behavior changes and motivate patients to 
adopt such strategies. 
Introduction 
Colorectal cancer (CRC) is a multifactorial disease, reflecting the interaction of hereditary and environmental factors. CRC 
was Oregon’s fourth most common cancer and second leading cause of cancer death in 2008 (1). Although 50% to 75% of 
CRC can be prevented through detection and removal of precancerous polyps (personal communication, Lieberman DA, 
May 2008), CRC screening rates remain below 70% in Oregon (2). Family history of CRC is an independent risk factor for 
developing the disease. 
Approximately 20% of CRC cases are associated with a 
family history, including 5% of CRC cases associated with 
single-gene cancer syndromes (3,4). People with a family 
history of CRC are 2.3 to 4.3 times more likely to develop 
CRC than those without it, depending on the number, 
relation, and age of onset of the relative(s) with cancer (5-
7). People whose relatives have early-onset CRC 
(diagnosed before age 50) are at higher risk than those 
with relatives diagnosed later in life (8). Consequently, 
several organizations recommend early screening for 
people with a positive family history, depending on the 
age at which the relative was diagnosed (Box) (9-11). 
Given the potential to reduce illness and death, early 
detection and prevention of CRC among people at high 
familial risk have important public health implications. 
These goals are achievable through clinician-mediated 
strategies (risk counseling, screening, or lifestyle 
modification recommendations) and patient-mediated 
strategies (risk-reducing lifestyle changes or use of 
Box. Guidelines or Clinical Considerations Pertaining 
to Colorectal Cancer (CRC) Screening for People at 
Increased Familial Risk
Organization Recommendation/Clinical 
Consideration
Screening 
Test
USPSTF For high-risk people (eg, 
those who have a first-
degree relative diagnosed 
with CRC at age <60 y), 
initiating screening at an 
earlier age (eg, age 50) is 
reasonable.
None 
specified.
ACS  the US 
For people with CRC or 
adenomatous polyps 
diagnosed in a first-degree 
relative at age <60 or in 2 
or more first-degree 
relatives at any age, begin 
screening at age 40 or 10 
Colonoscopy 
every 5 
years. None 
specified.
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screening). However, the frequency with which clinicians 
identify people with family history of CRC and provide 
them with preventive recommendations is poorly 
characterized (12). The objective of this study was to 
examine the relationship between family history of CRC 
and patient-reported clinician screening 
recommendations and patient preventive and screening 
behaviors among adults without CRC. We also examined 
associations of family history of CRC with other CRC risk 
factors and perceived risk of developing CRC. 
Methods 
We used data from the 2008 Oregon Behavioral Risk 
Factor Surveillance System (BRFSS), a statewide, 
random-digit–dialed telephone survey of health 
conditions and risk behaviors of the noninstitutionalized 
Oregon population aged 18 years or older, to estimate 
family history of CRC, health care provider practice, CRC 
screening, and preventive behavior. Detailed information 
about the Oregon BRFSS is available elsewhere (13). We 
weighted the data by age and sex to better reflect the 
demographic characteristics of adults in Oregon. The 
Oregon Health Authority deemed projects that use BRFSS 
data, including this project, to be exempt from review. 
Survey measures 
For this study, we classified respondents as having a family history if they reported at least 1 first-degree relative (parent, 
sibling, or child) with CRC and as having a family history of early-onset CRC if they reported at least 1 first-degree relative 
who was diagnosed with CRC before the age of 50. We classified respondents who reported no first-degree relatives with 
CRC or who reported they were adopted and did not know the medical history of their biological family members as having 
no family history. 
Additionally, we collected information about respondent-reported clinician recommendations on CRC risk and screening, as 
well as discussions about prevention and behaviors that might affect CRC risk. We also collected information about whether 
or not patients acted on clinicians' recommendations. 
We asked respondents, “Have you ever been told by a doctor, nurse, or other health care provider that you have colorectal 
cancer?” Respondents without CRC were asked the following questions: 
“Thinking of your close blood relatives, do you have a parent, brother or sister, or child who has been diagnosed with 
colorectal cancer by a health care provider?” If they responded yes, they were asked to identify which of these relatives had 
been diagnosed with CRC and to report the number of relatives who had been diagnosed with CRC before the age of 50. 
“Has a doctor, nurse, or other health care provider ever discussed the chances of you getting colorectal cancer?” 
“Has a health care provider ever discussed testing for colorectal cancer with you?” 
“Has a health care provider ever recommended changes in eating habits or physical activity to reduce your chances of 
getting diseases like colorectal cancer?” 
“How likely do you think it is that you will get colorectal cancer in the future?” 
“Have you made changes in your eating habits or physical activity to reduce your chances of getting diseases like colorectal 
cancer?” 
Respondents without CRC and who were aged 50 or older were asked whether they had ever had a CRC screening test, 
including fecal occult blood test (FOBT), sigmoidoscopy, or colonoscopy and the length of time since each test. We analyzed 
CRC screening prevalence by using 2 definitions: 1) ever having a colonoscopy, and 2) having CRC screening within the 
recommended time period based on the American Cancer Society and US Multi-Society Task Force on CRC guidelines for 
average-risk populations, which is either an FOBT within the past year, sigmoidoscopy within the past 5 years, or 
colonoscopy within the past 10 years (10). 
Potential covariates 
We analyzed the following potential covariates, which may affect associations among family history, health care provider 
recommendations, and patient behavior. Covariates included self-reported information on age, sex, education level, annual 
Multi-Society 
Task Force on 
CRC, and the 
American 
College of 
Radiology
years younger than the 
youngest diagnosis in the 
family, whichever comes 
first.
For people with CRC or 
adenomatous polyps 
diagnosed in a first-degree 
relative at age ≥60 or in 2 
second-degree relatives with 
CRC, begin screening at age 
40. 
None 
specified. 
NCCN Recommends different 
screening frequencies and 
ages to begin screening 
based on the age and 
number of relatives 
diagnosed with CRC.
Colonoscopy 
is always 
preferred 
for people 
with a 
family 
history.
Abbreviations: USPSTF, US Preventive Services Task 
Force; ACS, Amercian Cancer Society; NCCN, National 
Comprehensive Cancer Network.
ACS, the US 
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household income, marital status, race/ethnicity, leisure-time physical activity within the past month, obesity, smoking 
status, alcohol use, insurance status, and having 1 person the respondent thought of as their personal doctor or health care 
provider. We defined obesity as having a body mass index of 30 kg/m  or more, current smokers as people who reported 
smoking every day or some days and who reported having smoked 100 or more cigarettes during their lifetime, heavy 
alcohol use as consuming more than 2 alcoholic drinks per day on average for men and more than 1 alcoholic drink per day 
on average for women within the past month. 
Data analysis 
We used Pearson χ  tests and logistic regression to assess the association between respondents’ family history status and 
reported health care provider practices, perceived risk for developing CRC, preventive and screening behaviors, and risk 
factors for CRC. 
We included only covariates that were significantly associated with family history and the outcome variable in bivariate 
analyses in the multivariable logistic regression models. In the adjusted logistic regression models, we kept only covariates 
that changed the point estimate of the odds ratio (OR) by at least 10% (compared with the full model) in the final models. 
All analyses were performed using Stata version 11.0 (StataCorp LP, College Station, Texas). We reported sample sizes 
(number of survey respondents) as unweighted numbers and percentages as weighted estimates. 
Of the 1,841 people who responded to the family history questions, we excluded 29 because of missing or unknown 
information about family history of CRC and 17 additional respondents who had CRC. Our final sample for this analysis 
included 1,795 respondents without CRC. Although we were able to present the overall prevalence of respondents with 2 or 
more relatives with CRC, we were unable to stratify this group by other variables because of the small number of 
respondents (n = 9). 
Results 
The response rate for the Oregon 2008 BRFSS was 56%. Among respondents without CRC, 7.6% reported having a family 
history of CRC in first-degree relatives, and 1.1% were classified as having family history of early-onset CRC (Table 1). This 
translates into approximately 206,000 Oregonian adults without CRC with a positive family history and 30,000 Oregonian 
adults without CRC with family history of early-onset CRC (using a 2008 population estimate of 2.7 million Oregonian 
adults who had never been diagnosed with CRC). Of those with a family history, 4.6% (0.3% of the respondents without 
CRC) had 2 or more relatives with CRC. 
Several demographic characteristics varied by family history status. A higher proportion of people aged 50 to 64 years had a 
family history of CRC compared with those aged 18 to 49 years (Table 1). Whereas 20.4% of college graduates reported 
having a family history, none of the respondents with fewer years of formal education reported having a family history of 
CRC. Other characteristics, including whether the respondent reported having a personal health care provider, did not differ 
by familial risk. 
Respondents with a family history of CRC were more likely than those with no family history to report that their health care 
provider discussed the risk of developing CRC, discussed CRC screening, and recommended lifestyle changes to reduce the 
chance of developing CRC or other chronic conditions (Table 2). This result held true for the subset of respondents with 
family history of early-onset CRC. 
Those with a family history of CRC were more than 8 times as likely to believe that they were at high risk for developing 
CRC in the future as people without a family history (Table 3). This result held true for those with a family history of early-
onset CRC. Both those with any positive family history of CRC (OR, 2.6; CI, 1.7-4.0) and those with a family history of early-
onset CRC (OR, 4.2; CI, 1.5-11.7) were more likely to report changing their eating and physical activity habits to decrease 
their risk of disease than were respondents with no family history. Having a family history of CRC was associated with 
current smoking but not with leisure-time physical activity, obesity, alcohol consumption, or health insurance coverage. 
Among respondents aged 50 or older, those with a family history of CRC were more likely to report receiving screening for 
CRC within the recommended time frame for average-risk people than those without a family history (OR, 2.2; 95% CI, 1.3-
3.9) (Table 3). Family history of early-onset CRC was a predictor of having ever had a colonoscopy (OR, 3.3; 95% CI, 1.0-
10.7; P = .01). This result held true for the broader group of those with any family history of CRC (OR, 2.5; 95% CI, 1.5-4.2). 
Among respondents aged 50 or older who had a positive CRC family history, there was no significant difference in screening 
behavior between those with high perceived risk versus those with low perceived risk (data not shown). 
Discussion 
Our study found an association between family history of CRC and CRC screening, consistent with previous studies (14-16). 
Awareness of family history could mitigate risk for developing CRC through multiple mechanisms. First, it could motivate a 
person at risk to adopt behaviors or seek screening that may help prevent the disease or diagnose it at an early stage when it 
is most curable (patient-mediated effects). Second, it could motivate clinicians to counsel patients with a CRC family history 
about their risk for the disease, strategies to decrease that risk, and appropriate screening (clinician-mediated effects). 
Third, it could motivate people to be more receptive to comments and recommendations of their health care providers. 
2
2
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Patient-mediated effects, perceived risk, and behavior change 
The strong association in this study between family history of CRC and perceived risk of developing the disease is consistent 
with some prior studies involving other diseases (14-16), although the literature is inconsistent. However, as shown in this 
and other studies, there is no guarantee that high perceived risk will translate into risk-mitigating behavior. In a study of 
women with a family history of breast cancer, Drossaert et al noted that although these women had higher perceived risk, 
there were no differences in early-detection behavior between women with or without family histories of the disease (14). 
Some studies have suggested that heightened perceived risk leads to fatalism and actually impedes adaptive behavior to 
decrease risk (17,18). Other research has demonstrated that having a close family member with a chronic disease is 
associated not only with increased perception of risk but also with preventive and health-promoting behaviors (19-21). 
Another study of people who had first-degree relatives with CRC found that family history, perceived risk, and the belief 
that CRC can be prevented all increased the odds of CRC screening (22). Among respondents aged 50 or older in our study, 
whereas family history was associated with higher rates of screening, higher perceived risk was not. This could mean that 
simply being aware of one’s family history is a motivator for screening, and other preventive behaviors are independent of 
perceived risk. It is possible that other factors, such as interactions with health care providers, exert a stonger influence on 
screening behaviors (22). 
None of the respondents with less than a college education reported having a family history of CRC. It is unlikely that these 
people were entirely without family members diagnosed with CRC. This finding may reflect a difference in health literacy 
and awareness of the potential influence of family history on one’s personal health between college graduates and those 
with fewer years of formal education (23,24). Clinician assessment of health literacy in this area, followed by counseling 
about the potential value of family history information for patients who report no knowledge of their family history, could 
help address this disparity. 
Clinician-mediated effects 
Although prior studies have demonstrated that clinicians can be effective catalysts for behavior change in their patients 
(15,16), our study is the first of its kind to show a positive association between family history of CRC and reported discussion 
by clinicians about CRC screening and lifestyle changes intended to reduce disease risk. The literature is less clear about the 
extent to which clinicians collect family history information about screenable malignancies, such as CRC, and whether they 
then use this information to drive discussions with their family history–positive patients about familial risk and tailor 
subsequent screening recommendations. 
Those in our study with a family history of CRC were significantly more likely to report that their health care provider had 
discussed their risk of developing CRC with them and had recommended screening. This finding suggests that clinicians, 
once aware of relevant family history, appear to incorporate it into risk stratification, patient education, and screening 
decisions. 
Still, the low absolute percentages of respondents with a positive family history reporting that a health care provider 
engaged in discussions about risk of CRC or that they received recommendations on strategies to prevent CRC suggest many 
missed opportunities to educate people at increased risk of CRC and steps that could be taken to detect and prevent the 
condition. 
Incorporating family history into clinical practice is made more challenging by the absence of widely accepted standards for 
its collection and use (19). Although the use of family history tools on risk assessment and health outcomes has yet to be 
thoroughly researched, the authors of 1 review concluded that family history collection tools could add better family medical 
information compared with current primary care practice (25). 
This study has several limitations. First, causal inferences cannot be drawn from our cross-sectional data. Second, because 
survey data were self-reported, they are subject to recall bias. However, research has shown that most measures on the 
BRFSS are reliable and valid (26). Also, some studies have shown that people can accurately report their family history of 
CRC (27), whereas others indicate that family history of CRC is underreported (28). This is especially pertinent to our study 
because none of the respondents with less than a college education reported having a family history. Third, the response 
rate (56%), though well above the median for BRFSS response rates for all of the states, may have introduced nonresponse 
biases that affected the inferences drawn from this study. Fourth, BRFSS asked about screening for CRC only among 
respondents aged 50 or older. Consequently, we were unable to determine whether younger people with a positive family 
history were being screened according to guidelines for people at high familial risk. Fifth, having a family history of CRC 
could affect how people perceive and interact with their clinicians. For example, people with a family history of CRC may be 
more likely to recall that their clinician made recommendations and discussed risk for developing CRC and screening 
options, whereas people with no family history may be more likely to forget these interactions. Sixth, although we did 
capture information on first-degree relatives with CRC and the age of onset of the disease, we did not ask about second- or 
third-degree relatives. Lastly, clinician behavior was reported by the respondents in the survey and was not actually 
observed or reported by the clinicians themselves. 
Implications for public health policy and future research 
The finding that having a family history of CRC is associated with higher rates of screening for this condition could be due to 
personal motivation, mediated by health care provider counseling and screening recommendations, or a mixture of both. 
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Although people with a family history of CRC were more likely to report clinician risk counseling and recommendations to 
undertake screening, the absolute percentages receiving such counseling and recommendations were low. Development and 
dissemination of evidence-based, systematic clinician training could increase clinicians’ ability to collect CRC-related family 
history information and improve their awareness of how to use that information most effectively in counseling and 
screening. Clinician training could also provide necessary skills to assess patient health literacy in this area and, 
subsequently, help those with limited knowledge of their family history gain a better understanding of their risk of disease. 
Universal, timely screening for CRC among people at increased risk due to family history would prevent disease and save 
lives. To accomplish this goal, clinicians require efficient decision support tools and consistent evidence-based guidelines 
related to family history. Future translational studies are needed that facilitate use of family history information to motivate 
clinicians and their patients to pursue appropriate CRC screening. 
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Characteristic n
No Family History
% (95% CI)
Any Family History
% (95% CI)
Early-Onset Family History
% (95% CI)
Total 1,795 92.4 (90.9-93.7) 7.6 (6.3-9.1) 1.1 (0.7-1.8)
Age, y
18-49 626 94.5 (92.2-96.2) 5.5 (3.8-7.8) 0.7 (0.3-1.8)
50-64 625 89.2 (86.4-91.5) 10.8 (8.5-13.6) 1.5 (0.7-2.8)
≥65 538 90.4 (87.2-92.8) 9.6 (7.2-12.8) 2.0 (1.0-4.2)
Sex
Male 696 93.3 (91.0-95.1) 6.7 (4.9-9.0) 0.8 (0.3-1.7)
Female 1,099 91.6 (89.5-93.3) 8.4 (6.7-10.5) 1.5 (0.9-2.6)
Education
High school or less 587 587 (100) 0 0
Some college 535 535 (100) 0 0
College graduate 663 79.6 (75.8-83.0) 20.4 (17.0-24.2) 3.3 (2.1-5.2)
a
b c d 
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Abbreviations: CRC, colorectal cancer; CI, confidence interval. 
 Numbers for some variables do not total 1,795 because of missing data. 
 No first-degree relatives diagnosed with CRC or adopted with unknown family history status of blood relatives. 
 One or more first-degree relatives diagnosed with CRC. 
 One or more first-degree relatives aged <50 y diagnosed with CRC. 
 Reported having 1 person whom the respondent thought of as his or her personal doctor or health care provider. 
  
Table 2. Prevalence and Odds Ratios for Clinician Practices and 
Recommendations to Prevent CRC, by Family History of CRC, 2008 Oregon 
Behavioral Risk Factor Surveillance System 
Abbreviations: CRC, colorectal cancer; CI, confidence interval; OR, odds ratio. 
 No first-degree relatives diagnosed with CRC or adopted with unknown family history status of blood relatives.
One or more first-degree relatives diagnosed with CRC. 
 One or more first-degree relatives aged <50 y diagnosed with CRC. 
 Adjusted for education. 
 Adjusted for education and age. 
 Adjusted for education, age, and smoking status. 
Marital status
Not married 670 94.1 (91.4-96.1) 5.9 (3.9-8.6) 1.3 (0.5-3.2)
Married 1,119 91.7 (89.8-93.3) 8.3 (6.7-10.2) 1.0 (0.6-1.7)
Rurality
Urban 1,348 92.6 (90.9-94.0) 7.4 (5.9-9.1) 1.2 (0.7-2.0)
Rural 447 92.0 (88.5-94.5) 8.1 (5.6-11.5) 1.0 (0.5-2.3)
Annual household income, $
<25,000 374 92.9 (89.4-95.4) 7.1 (4.6-10.6) 1.8 (0.8-4.7)
25,000-49,999 508 91.5 (88.3-93.8) 8.5 (6.2-11.7) 1.3 (0.7-2.7)
≥50,000 708 92.2 (89.7-94.1) 7.8 (5.9-10.3) 1.0 (0.5-2.0)
Personal doctor/health care provider
No 255 94.6 (90.7-96.9) 5.4 (3.0-9.3) 1.2 (0.3-4.0)
Yes 1,535 91.8 (90.1-93.2) 8.2 (6.8-9.9) 1.2 (0.8-2.0)
Practice/Recommendation
No Family 
History
% (95% CI)
Any Family 
History
% (95% CI)
Early-Onset 
Family History
% (95% CI)
Any Family 
History
OR (95% CI) 
(vs No Family 
History)
Early-Onset Family 
History
OR (95% CI) 
(vs No Early-Onset 
Family History)
Discussion of CRC risk
No 88.5 (86.8-
90.0)
51.7 (42.5-
60.9)
50.7 (28.8-72.3) 1 [Reference] 1 [Reference]
Yes 11.5 (10.0-
13.2)
48.3 (39.1-
57.5)
49.3 (27.7-71.2) 8.9 (5.5-14.3) 5.3 (2.0-13.9)
Discussion of CRC screening
No 70.5 (68.0-
72.9)
36.8 (26.6-
46.1)
26.4 (9.3-55.6) 1 [Reference] 1 [Reference]
Yes 29.5 (27.1-
32.0)
63.2 (52.7-
72.5)
73.6 (44.4-90.7) 4.2 (2.4-7.4) 6.7 (1.6-27.8)
Lifestyle change recommendations
No 89.6 (84.8-
88.7)
69.2 (60.5-
76.7)
52.7 (30.7-73.7) 1 [Reference] 1 [Reference]
Yes 13.1 (11.3-
15.2)
30.8 (23.3-
39.5)
47.3 (26.3-69.3) 2.6 (1.7-4.1) 4.2 (1.5-11.7)
e
a
b
c
d
e
a b c 
b c 
d d
e f
g
f f
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c
d
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f
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 Health care provider ever recommended changes in eating habits or physical activity to reduce the chances of getting diseases 
such as CRC. 
  
Table 3. Prevalence and Odds Ratios for Perceived Risk, Risk Factors, and 
Screening Behaviors for CRC, by Family History of CRC, 2008 Oregon 
Behavioral Risk Factor Surveillance System 
Characteristic/ 
Behavior
No Family 
History
% (95% CI)
Any Family 
History
 % (95% CI)
Early-Onset Family 
History
% (95% CI)
Any Family 
History
OR (95% CI) 
(vs No Family 
History)
Early-Onset Family 
History
OR (95% CI) 
(vs No Early-Onset 
Family History)
Perceived risk of CRC
Low 92.5 (90.6-
94.1)
54.2 (44.3-
63.8)
44.7 (23.4-68.1) 1 [Reference] 1 [Reference]
High 7.5 (5.9-9.4) 45.8 (36.2-
55.7)
55.3 (31.9-76.6) 8.5 (4.6-15.7) 8.7 (3.1-24.1)
Reported lifestyle changes
No 67.7 (64.9-
70.5)
43.4 (34.2-
53.0)
29.0 (12.9-53.0) 1 [Reference] 1 [Reference]
Yes 32.3 (29.5-
35.1)
56.6 (47.0-5.8) 71.0 (47.0-87.1) 2.6 (1.7-4.0) 4.2 (1.5-11.7)
Any leisure-time physical activity within the past month
No 20 (17.4-22.8) 17.8 (11.9-
25.7)
28.8 (12.8-52.8) 1 [Reference] 1 [Reference]
Yes 80 (77.2-82.6) 82.2 (74.3-
88.1)
71.2 (47.2-87.2) 0.9 (0.5-1.4) 1.5 (0.6-4.6)
Obesity (BMI >30 kg/m )
No 73.1 (70.0-
76.0)
70.2 (60.8-
78.2)
58.5 (34.0-79.4) 1 [Reference] 1 [Reference]
Yes 26.9 (24.0-
30.0)
29.8 (21.8-
39.2)
41.5 (20.6-66.0) 1.2 (0.7-1.8) 1.9 (0.7-5.3)
Current smoker
No 86.4 (84.0-
88.4)
75.1 (64.4-
83.3)
77.1 (47.0-92.7) 1 [Reference] 1 [Reference]
Yes 13.6 (11.6-
16.0)
24.9 (16.7-
35.6)
22.9 (7.3-53.0) 2.3 (1.4-4.0) 1.9 (0.5-7.2)
Heavy alcohol use
No 95.5 (94.1-
96.5)
92.2 (84.7-
96.2)
100 1 [Reference] 1 [Reference]
Yes 73 (3.5-5.9) 11 (3.8-15.3) 0 1.5 (0.7-4.0) NA
Health insurance coverage
No 16.6 (14.0-
19.6)
10.2 (5.0-19.7) 17.0 (3.9-50.5) 1 [Reference] 1 [Reference]
Yes 83.4 (80.4-
86.0)
89.8 (80.3-
95.0)
83.0 (49.5-96.1) 0.5 (0.2-1.0) 1.2 (0.3-5.3)
Colonoscopy ever
No 46.3 (42.9-
49.7)
23.3 (16.3-
32.2)
16.7 (6.0-38.6) 1 [Reference] 1 [Reference]
Yes 53.7 (50.3-
57.1)
76.7 (67.8-
83.7)
83.3 (61.4-94.0) 2.5 (1.5-4.2) 3.3 (1.0-10.7)
a b 
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b c 
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e f f
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For Questions About This Article Contact pcdeditor@cdc.gov 
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, 
USA 
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, New Hours of Operation 
8am-8pm ET/Monday-Friday 
Closed Holidays - cdcinfo@cdc.gov 
Page last reviewed: December 15, 2011  
Page last updated: December 15, 2011  
Content source: National Center for Chronic Disease Prevention and Health Promotion  
Abbreviations: CRC, colorectal cancer; CI, confidence interval; OR, odds ratio; BMI, body mass index; NA, not applicable. 
 No first-degree relatives diagnosed with colorectal cancer or adopted with unknown family history status of blood relatives. 
 One or more first-degree relatives diagnosed with colorectal cancer. 
 One or more first-degree relatives aged <50 y diagnosed with colorectal cancer. 
 Reported very or somewhat unlikely or neither likely nor unlikely to develop CRC in the future. 
 Reported very or somewhat likely to develop CRC in the future. 
 Adjusted for education. 
 Reported making changes in eating habits or physical activity to reduce the chances of getting diseases such as colorectal 
cancer. 
 Adjusted for age and smoking status. 
 Adjusted for age. 
 Defined as >2 drinks per day on average for men and >1 alcoholic drink per day on average for women within the past month. 
 Adjusted for smoking status. 
  Among respondents aged ≥50. 
Fecal occult blood testing within the past year, sigmoidoscopy within the past 5 y, or colonoscopy within the past 10 y. 
Adjusted for education and smoking status. 
CRC screening
No 36.8 (33.5-
40.3)
16.8 (11.0-
24.9)
12.3 (3.8-33.3) 1 [Reference] 1 [Reference]
Yes 63.2 (59.7-
66.5)
83.3 (75.1-
89.0)
87.7 (66.7-96.2) 2.2 (1.3-3.9) 2.4 (0.7-8.8)
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